TMS Neuro Institute Opens New Offices in Los Angeles

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
36
TMS Neuro Institute Opens New Offices in Los Angeles Offering Patients Effective Treatment for Depression Without the Use of Drugs

LOS ANGELES, Nov. 28, 2017 (GLOBE NEWSWIRE) -- TMS Neuro Institute, led under the direction of Dr. Gennady Musher, MD, Phd, and Faculty Member at UCLA, has officially opened its doors in Los Angeles. The brand new facility was designed to treat patients in a relaxing setting complete with luxurious treatment rooms and high tech equipment.

The offices are expected to be open five days a week under the direction of TMS Neuro Institute’s founder Dr. Musher.  He is an expert in using TMS therapy to treat resistant depression and has seven years of experience and specialty training in neuromodulation techniques. Dr. Musher has 25 years of experience in psychopharmacology treatment of multiple psychiatric disorders. He is also an expert in the treatment of resistant depression with Transcranial Magnetic Stimulation (TMS) with seven years of experience and specific training in neuromodulation techniques.

He has been in private practice since 1998 and has experience in the evaluation and treatment of major psychiatric conditions including, but not limited to: major depressive disorder, anxiety disorders, psychotic disorders, mood disorders and forensic evaluations. Dr. Musher is also a faculty member at UCLA.

“At TMS Neuro Institute we can offer patients from 22 to 85 the best alternative treatment in Los Angeles,” said Dr. Gennady Musher. “With more and more opportunities to use treatment without medication, we are confident that patients will complete their treatment in six weeks.”

TMS is an effective treatment alternative for patients who do not respond well to antidepressant medication or psychotherapy or who do not want to take medications with harsh side effects. For example, some patients are not able to take antidepressant medications due to pre-existing medical conditions, others have treatment resistant depression and some patients just prefer a drug-free treatment option. Patients can also remain on their antidepressant medications throughout the TMS treatment process—it’s safe with or without medication.

ABOUT TMS Neuro Institute:

TMS Neuro Institute is one of the earliest adopters in using TMS therapy to treat depression in Southern California. We have successfully helped thousands of patients for whom the traditional methods of treating depression—medication and psychotherapy—did not work.

For more information please visit https://tmsneuroinstitute.com.

CONTACT: AMY PRENNER (310) 709-1101

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading